In summary, these data clearly show that pancreatic cancer cell lines are overall highly and moderately sensitive to PD-H, moderately sensitive to H3N-375/1TS, but almost completely resistant to CVA21. This evidence concerns the gene PDP1 and familial pancreatic carcinoma.